Table 3

OR and 95% CI of patient demographic and clinical characteristics associated with actual place of death*

HomeCare homeHospice
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
Gender
Male1.001.001.00
Female1.04 (0.74 to 1.48)0.8082.46 (1.60 to 3.77) <0.001 1.26 (0.81 to 1.98)0.309
Age at death (years)
≤741.001.001.00
75+0.99 (0.70 to 1.39)0.95111.42 (5.21 to 25.10) <0.001 0.83 (0.53 to 1.29)0.400
IMD category*
Most affluent11.001.001.00
21.21 (0.81 to 1.81)0.3631.49 (0.92 to 2.44)0.1091.05 (0.62 to 1.79)0.863
Most deprived31.02 (0.67 to 1.57)0.9140.98 (0.57 to 1.68)0.9291.00 (0.58 to 1.74)0.988
First diagnosis
DLBCL†1.001.001.00
Myeloma‡1.52 (0.85 to 2.75)0.1590.47 (0.22 to 1.03)0.0580.76 (0.32 to 1.82)0.540
AML§1.10 (0.57 to 2.09)0.7940.36 (0.15 to 0.89) 0.027 1.01 (0.43 to 2.37)0.988
MDS¶1.23 (0.64 to 2.37)0.5350.41 (0.17 to 1.01)0.0521.03 (0.43 to 2.49)0.942
CLL**1.38 (0.69 to 2.78)0.3640.96 (0.44 to 2.09)0.9211.42 (0.58 to 3.46)0.443
MPN††2.30 (1.13 to 4.69) 0.021 2.16 (1.04 to 4.49) 0.038 1.28 (0.45 to 3.62)0.647
Other0.97 (0.55 to 1.72)0.9250.81 (0.44 to 1.47)0.4811.47 (0.74 to 2.95)0.273
Time from diagnosis to death (months)
0–6 months0.65 (0.43 to 0.99) 0.044 0.94 (0.58 to 1.51)0.7950.42 (0.22 to 0.79) 0.007
6+ months1.001.001.00
Underlying cause of death‡‡
Haematological malignancy0.89 (0.62 to 1.28)0.5310.71 (0.46 to 1.09)0.1161.37 (0.83 to 2.28)0.220
Other1.001.001.00
Patient lived alone§§
Yes0.88 (0.59 to 1.29)0.5060.68 (0.41 to 1.13)0.1341.70 (1.07 to 2.69) 0.025
No/unknown1.001.001.00
Hospital-based SPC¶¶ referral
Yes1.24 (0.87 to 1.72)0.2450.46 (0.27 to 0.78) 0.004 5.85 (3.54 to 9.66) <0.001
No1.001.001.00
Preferred place of death discussion recorded
Yes1.90 (1.34 to 2.68) <0.001 1.87 (1.34 to 2.68) 0.005 5.24 (3.07 to 8.94) <0.001
No1.001.001.00
  • Bold font indicates statistical significance.

  • *Reference category is hospital death.

  • †Index of Multiple Deprivation (income domain): one patient with missing data.

  • ‡Diffuse large B-cell lymphoma.

  • §Acute myeloid leukaemia.

  • ¶Myelodysplastic syndromes.

  • **Chronic lymphocytic leukaemia.

  • ††Myeloproliferative neoplasms.

  • ‡‡Derived from death certificate data, Medical Research Information Service.

  • §§Patient lived alone: ‘No’ includes 24 patients where it was ‘unknown’.

  • ¶¶Specialist palliative care: ‘No’ includes 25 patients where SPC is ‘Unknown’.